PRC Shows DiDi Who's Boss: An Analysis of Adverse Regulatory Events on Stock Prices
Last week, I wrote about DiDi's regulatory risk. This week, it's worse. Hence the downgrade. But this is mostly an analysis of how regulatory...
461 Views
HutchMed Secondary Listing: HK-ADS Premium/āāā(Discount) Views
HutchMed has launched a $603 million secondary listing on HKEx. In this note, we will look at HutchMedās potential HK-ADS premium/(discount).
409 Views
51job's Buyout: Offer Price Unchanged In Updated Proposal
Trading at a gross spread of 15.9%.Ā With a seasoned player such as Ocean Link now in the mix, plus the CEO, a definitive agreement looks more...
457 Views
Waterdrop IPO: Valuation Insights
Waterdrop has launched its IPO to raise net proceeds of $301.6 million at the mid-point of the price range of $10-12. The price range is full at...
474 Views
ECM Weekly (18th April 2021) - ByteDance Zhaoke, We Doctor, Medlive, Bio-Thera, Grab, Ngern Tid Lor
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
496 Views